Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on August 23, 2021. The report addresses corporate governance events regarding the Company's Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate event and does not contain financial statement data.
Material Changes
The primary event reported is the failure to achieve a quorum at the reconvened Annual Meeting of Shareholders held on August 23, 2021. The meeting had originally been scheduled for June 30, 2021. Due to insufficient shares being present or represented by proxy, no business was conducted.
Outlook and Management Commentary
The Board of Directors has decided to reschedule the Annual Meeting for a date yet to be determined. A new record date will be established, and shareholders entitled to notice will be notified of the new meeting date. A press release announcing this postponement was issued on August 24, 2021.
Key Facts for Investor Verification
- The Annual Meeting failed to achieve a quorum on August 23, 2021.
- The meeting has been postponed indefinitely pending a new date set by the Board.
- A new record date will be established for the rescheduled meeting.
- Shareholders should monitor future communications for the new meeting date and record date.